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How should we manage information needs,
family anxiety, depression, and breathlessness
for those affected by advanced disease:
development of a Clinical Decision Support
Tool using a Delphi design
Liesbeth M. van Vliet1*, Richard Harding1, Claudia Bausewein2, Sheila Payne3, Irene J. Higginson1
and on behalf of EUROIMPACT
Abstract
Background: Clinicians request guidance to aid the routine use and interpretation of Patient Reported Outcome
Measures (PROMs), but tools are lacking. We aimed to develop a Clinical Decision Support Tool (CDST) focused on
information needs, family anxiety, depression, and breathlessness (measured using the Palliative care Outcome Scale
(POS)) and related PROM implementation guidance.
Methods: We drafted recommendations based on findings from systematic literature searches. In a modified online
Delphi study, 38 experts from 12 countries with different professional backgrounds, including four patient/carer
representatives, were invited to rate the appropriateness of these recommendations for problems of varying
severity in the CDST. The quality of evidence was added for each recommendation, and the final draft CDST
reappraised by the experts. The accompanying implementation guidance was built on data from literature
scoping with expert revision (n = 11 invited experts).
Results: The systematic literature searches identified over 560 potential references, of which 43 met the
inclusion criteria. Two Delphi rounds (response rate 66 % and 62 %; n = 25 and 23) found that good patient
care, psychosocial support and empathy, and open communication were central to supporting patients and
families affected by all POS concerns as a core requirement. Assessment was recommended for increasing
problems (i.e. scores), followed by non-pharmacological interventions and for breathlessness and depression,
pharmacological interventions. Accompanying PROM implementation guidance was built based on the 8-step
International Society for Quality of Life Research framework, as revised by nine (response rate 82 %) experts.
Conclusions: This CDST provides a straightforward guide to help support clinical care and improve evidence-based
outcomes for patients with progressive illness and their families, addressing four areas of clinical uncertainty.
Recommendations should be used flexibly, alongside skilled individual clinical assessment and knowledge, taking
into account patients’ and families’ individual preferences, circumstances, and resources. The CDST is provided with
accompanying implementation guidance to facilitate PROM use and is ready for further development and evaluation.
Keywords: Clinical decision support tools, Delphi studies, Implementation, Palliative care, Palliative care outcome scale
(POS), Patient reported outcome measures
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Background
Providing optimal care to patients facing life-threatening
and progressing illnesses requires a focus on patients’
and their family caregivers’ physical, psychological, emo-
tional, and spiritual needs [1]. It is not solely a task of
experts in palliative care. The number of people affected
by chronic and progressive illness is escalating, fueled by
population ageing and improved life expectancy [2].
While specialist palliative care services, such as hospices
and home care teams, provide an extra layer of support
for those with the most complex needs, patients and
their families with progressive and life threatening illness
come into contact with health and social care workers in
all settings – primary, secondary, and tertiary. Providing
holistic care for seriously ill patients and their families is
now a central component of health care [3]. This can,
however, be daunting for many doctors, nurses and
other staff, especially with limited formal (undergraduate
and postgraduate) training [4, 5].
An important starting point in effective clinical man-
agement is the assessment and identification of problems
[6]. Unfortunately, practitioners often miss many of
patients’ needs and symptoms, especially when these are
non-physical [7–11]. This problem is compounded be-
cause patients have multiple symptoms and concerns
[12–14]. Asking patients to report their concerns using
Patient Reported Outcome Measures (PROMs) has been
proposed as a way to overcome this [15]. When repeated
over time, such assessments can become measurable
outcomes, revealing how patients’ health status changed
following the care provided [16].
Although practitioners express positive attitudes to-
wards measuring PROMs [17, 18], routine measurement
of concerns is hampered by a lack of training and
guidance on how to use and respond to PROMs in clin-
ical care [17–19]. Published guidance on using PROMs
[20–22] is fragmented; it lacks specified steps and rec-
ommendations to follow when implementing PROMs
[20, 21] or does not focus on advance disease [22]. Even
more pressing, there is a lack of guidance on how to re-
spond to specific PROM scores. There is often an un-
familiarity with the score interpretation [23], while
PROM scores are potentially not fed back to the right
person, or reported as often as needed [24]. Clinical sig-
nificance of health-related quality of life scores are not
always reported in studies [25, 26]. Unsurprisingly,
therefore, clinical decision-making is not often based on
outcome scores [27] and measuring PROMS seems to
have a stronger impact on process-aspects of care, i.e.
detection of symptoms, than on outcome-aspects of
care, i.e. patients’ health status (e.g. [15, 23, 28, 29]).
Ideally, PROMs should routinely be used and assist in
detecting problems, planning treatment, and monitoring
how well concerns are alleviated.
To fill this gap we need specific clinical decision sup-
port aids for specific PROM scores. This should be
linked with better focused guidance on how to imple-
ment PROMs in routine clinical practice. It is important
that both sets of guidance are developed together. This
will ensure specific PROMs are successfully imple-
mented in clinical care, while at the same time clinicians
are supported in using the PROMs when responding to
concerns.
One of the most widely used outcome measures in
clinical practice in advanced illness is the Palliative (or
Patient) care Outcome Scale (POS) family of measures
(consisting of the POS, Integrated POS (IPOS), African
Palliative Care Association African POS (APCA African
POS), and POS-Symptoms (POS-S)) [30]. It assesses phys-
ical symptoms, emotional, psychological, and spiritual con-
cerns, and needs for information and support [31]. It is
brief (<10 minutes to complete), widely validated, able to
transfer across settings, has good responsiveness to
change, and has been translated and/or culturally
adapted and revalidated in many different languages and
cultures (e.g. [32–34]). A full suite of free user support
resources is available at www.pos-pal.org [35]. During a
training day on POS in 2013, we identified clinicians’ need
for guidance in the interpretation of and responding to
POS scores. Most difficulties were encountered with inter-
preting the questions regarding psychological functioning
(i.e. depression/feeling worthwhile, n = 18/36 comments),
information provision (n = 7/36 comments), and family
anxiety (n = 4/36 comments). Breathlessness is a very dis-
turbing symptom for patients [36, 37] and their families
[38]. Creation of evidence-based clinical guidance on
how to respond to these concerns is needed.
The aim of this study was therefore to develop a
Clinical Decision Support Tool (CDST) for the specific
POS items of most concern to clinicians: information
needs, family anxiety, depression, and breathlessness.
The guidance is aimed for all practitioners and settings,
and is applicable to all patients/family caregivers with
complex needs and progressive, life-threatening and
serious disease. Because successful implementation of
PROMs in clinical practice is a precondition to using a
CDST, but current guidance is fragmented, in parallel
we also developed accompanying guidance on PROM
implementation. This article reports the development
and final formats of the CDST and implementation guid-
ance. It also offers a novel methodological approach for
CDSTs in other areas.
Methods
Design
A systematic literature search and modified Delphi study
were conducted to develop the CDST. A literature
search and expert consultations were used to create the
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PROMs implementation guidance. Ethical approval was
granted by the Research Ethical Committee of King’s
College London (BDM/13/14-3). Participants were ex-
plained that participation implied informed consent.
Clinical Decision Support Tool (CDST)
The CDST on how to respond to different levels of re-
ported POS scores on information needs, family anxiety,
depression, and breathlessness was created using a system-
atic literature search to develop preliminary recommenda-
tions for clinical care, followed by a modified Delphi
approach to determine how the recommendations should
be applied for different levels of POS score severity.
Systematic literature search
Search strategy
To develop draft recommendations we searched for
guidelines and systematic reviews on the aforementioned
topics in PubMed, Google Scholar (first 4 pages),
Cochrane Database, and the York DARE database (2000
to end June 2013). The websites of NICE (UK), National
Guideline Clearinghouse (US), the Canadian Medical
Association, and google.com (first 4 pages) were hand
searched for relevant guidelines. Three guides on using
PROMS were screened for relevant information [20–22]
(see Additional file 1 for search strategies).
Inclusion criteria were:
i). Guidelines/systematic reviews focusing on general
palliative care, or focusing on information needs,
family anxiety, depression, or breathlessness in
palliative care (sources focusing on palliative care in
a specific setting were included)
ii). Guidelines/systematic reviews published in English/
Dutch/German/Italian (languages available in the
study team)
iii). Guidelines from national (disease) organizations
iv). Guidelines providing an evidence-base for created
recommendation
v). Systematic reviews published in peer-reviewed journals
Exclusion criteria were guidelines/systematic reviews:
i). Not focusing solely on palliative care (but on the
entire trajectory of disease(s))
ii). Focusing on a specific disease
iii). Focusing solely on pediatric care
iv). Of which an updated version was available
v). Of which no full-text was available
Data extraction
Data from included sources on how to clinically respond
to information needs, family anxiety, depression, and
breathlessness was extracted (by LV).
Analysis
LV drafted recommendations based on the extracted evi-
dence. These were then critically revised by the co-
authors (RH, CB, SP). Two authors (LV/IH) finalized the
draft recommendations which were then taken forward
into the subsequent modified Delphi study.
Modified Delphi study
We conducted a two-round online Delphi-study [39, 40]
(hosted via internet platform Keypoint), to appraise and
revise the draft recommendations and agree an expert
consensus on the appropriateness of all recommenda-
tions for all scores on the POS items.
Participants
Overall, 38 experts were purposefully sampled (we
approached 48, of which 10 declined beforehand); com-
prising 26 clinicians, 24 researchers (some had a dual
role), and 4 patient/family representatives (as experts
by experience, recruited via the UK National Council
of Palliative Care and the European Cancer Patient
Coalition). Experts came from the UK, US, Netherlands,
Italy, Germany, Australia, South Africa, Belgium, Greece,
Sweden, Poland, and Switzerland. Experts were chosen
based on their expertise in the field of the topics under
study.
Ratings
In the Delphi round 1, experts rated the appropriateness
of recommendations for all the different answer categor-
ies (0–4) for each POS-item and provided comments
and/or suggested revisions. Appropriateness was rated
on a 1–9 scale (‘not at all appropriate’ to ‘extremely ap-
propriate’) with a ‘do not know’ option and space for
comments. In round 2, a summary of the results of
round 1 was provided (median, range, interquartile
ranges, summary qualitative remarks) which participants
were asked to take into account when rating the recom-
mendations again. The results of round 1 were circu-
lated. If recommendations in round 2 achieved a median
ranging 7–9 and did not have >30 % of scores in the
1–3 and 7–9 range, they were deemed as appropriate
[41–43] and included in the CDST. Lastly, the draft
CDST was commented upon by (the same, plus one
additional) experts via email and in a face-to-face re-
search meeting (with different researchers).
Quality of evidence
For each recommendation, the quality of evidence was
determined, using an adapted GRADE approach [44]
with the classifications: A (e.g. meta-analysis, systematic
review of randomized controlled trials (RCTs), RCT), B
(e.g. cohort studies, case–control studies), C (e.g. retro-
spective, poor quality cohort studies), and D (qualitative
van Vliet et al. BMC Medicine  (2015) 13:263 Page 3 of 20
studies, expert opinion) quality evidence. We rated each
recommendation using the most recent and highest level
of known evidence (based on design). If sources already
provided a quality rating, their rating was used. Additional
file 2 depicts how quality ratings from each source were
mapped to the ABCD framework.
Accompanying guidance on implementing PROMs
We scoped the literature for relevant guidance on imple-
menting PROMs. Data was extracted from these sources
to develop (with assistance of several experts in the field)
a draft implementation guidance linked to our specific
PROM, the POS. Next, we invited comments and critical
revisions via email from the 10 members of the European
Association for Palliative Care (EAPC) Taskforce Outcome
Measures (we approached 13, of which three declined
beforehand), plus one additional expert who agreed to
participate, representing the countries of the UK, US,
Germany, Australia, Italy, Belgium, and South Africa. A fi-
nalized version was created with comments from one add-
itional expert.
Results
Clinical Decision Support Tool (CDST)
Systematic literature search
Our search of the online databases revealed 703 sources
(564 after duplication removal) of which 31 were
included (see Fig. 1 for the flowchart of inclusion) [45–75].
Two additional guidelines [76, 77] were added as they were
referred to by two included references [49, 73]. In addition,
nine extra guidelines were included from the screened
websites [78–86]. As panic/anxiety is often associated with
breathlessness, we screened the NICE and Clearinghouse
websites and all included guidelines for additional sources,
revealing one additional source [87]. Therefore, ultimately
43 sources were included.
All included sources were scrutinized for evidence-
based conclusions, data and recommendations on how
to clinically respond to information needs, family
anxiety, depression, and breathlessness in palliative care.
Overall, 47 recommendations were drafted to be rated in
the Delphi Round 1. Not all included sources provided
information that could be used to draft recommenda-
tions, e.g. one review focusing on the effect of home-
based palliative care found inconsistent results. As no
other source focused on this topic, no recommendations
about home-based care were made [72].
Modified Delphi study
In total, 25/38 (66 %) of our experts participated in
round 1. Open comments were used to adjust wordings
of several recommendations (services should be ‘offered’
instead of ‘provided’; pharmacological interventions should
be ‘offered, alongside non-pharmacological interventions’).
For round 2, experts were asked to take into account a
summary of the qualitative and quantitative results of
round 1. In this second round, 62 % (23/37, one person
withdrew from the project) of the experts participated.
Demographic characteristics of participating experts in
rounds 1 and 2 are displayed in Additional file 3. Open
comments (services should be provided, ‘depending on re-
sources’; psycho-education, ‘i.e. teaching, explanation’) were
used to finalize the recommendations, while the predefined
cut-offs were used to draft the CDST. Quality of evidence
was added for each recommendation, ranging from high to
very low (later adapted to A–D). One recommendation
(regarding chest-wall vibration to treat breathlessness) was
downgraded from A to B as evidence was based on labora-
tory (as opposed to clinical) studies.
Final clinical decision support tool
Two formats of a decision-diagram for each POS item
and a manual of the CDST were created and again sent
out to all experts, of which 41 % (15/37) provided com-
ments, in addition to one other expert in the field. Main
comments focused on making it clear that for higher
POS scores, lower recommendations still apply and
creating both a short and long manual, while both
formats of the decision diagrams were equally pre-
ferred (also in the face-to-face researchers meeting).
The final decision-diagrams are depicted in Figs. 2, 3, 4,
5, 6, 7, 8 and 9. Additional file 4 depicts the short manual
while the long manual can be found at the Palliative care
Outcome Scale website [35]. Independent of POS score,
core recommendations center on: i) good patient care,
ii) the provision of psychosocial support and empathy,
and iii) the use of open communication. Proper as-
sessment is needed for increasing scores, followed by
non-pharmacological interventions, and pharmaco-
logical interventions for high levels of depression and
breathlessness.
Implementation guidance
Our scoping identified four major guides which had
complementary approaches: i) the PROMs guidelines of
the International Society for Quality of Life Research
(ISOQOL) including an 8-step framework [22], ii) the
Outcome Measures in Palliative Care booklet [20],
iii) the White paper on Outcome Measures of the
EAPC [21], and iv) for the POS family of measures,
the Guidelines for using the POS [88]. To provide
guidance on implementing PROMs in clinical practice, the
ISOQOL’ [22] 8-step framework was followed. The 8 steps
include i) identify goals for collecting PROMs; ii) select
patients, setting, and timing of assessment; iii) determine
which questionnaire to use; iv) choose a mode for
administering/scoring the questionnaire; v) design pro-
cesses for reporting results, vi) identify aids to facilitate
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score interpretation; vii) develop strategies for responding
to identified issues; and 8) evaluate the impact of measuring
PROMs on practice. We amalgamated consistent rec-
ommendations from the different sources into this
framework.
In total, 9/11 (82 %) of the invited participants pro-
vided comments on the guidance (in addition to one
other expert in the field). The comments stressed the
need to define the target group, present tables/boxes,
and introductory passages, and these were integrated
into the final guidance. The key recommendations of the
implementation guidance are summarized in Table 1 for
each step (the complete guidance can be found at [35]).
Discussion
This is the first study to develop a CDST for some of the
complex problems faced in advanced disease, in particular
information needs, family anxiety, depression, and breath-
lessness, linking these to specific actions. The CDST has an
evidence-based approach, responding to different levels of
Fig. 1 PRISMA flowchart inclusion guidelines/systematic reviews Clinical Decision Support Tool
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Fig. 2 Final decision diagrams. Legends: POS score decision diagrams format 1. Information needs
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Fig. 3 Final decision diagrams. Legends: POS score decision diagrams format 1. Family anxiety
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Fig. 4 Final decision diagrams. Legends: POS score decision diagrams format 1. Depression
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Fig. 5 Final decision diagrams. Legends: POS score decision diagrams format 1. Breathlessness
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Fig. 6 Final decision diagrams. Legends: POS score decision diagrams format 2. Information needs
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Fig. 7 Final decision diagrams. Legends: POS score decision diagrams format 2. Family anxiety
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Fig. 8 Final decision diagrams. Legends: POS score decision diagrams format 2. Depression
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Fig. 9 Final decision diagrams. Legends: POS score decision diagrams format 2. Breathlessness
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Table 1 Implementation guidance key recommendations
Step Key recommendations
1 Identify the goals for collecting Patient Reported Outcome
Measures (PROMs)
Measuring PROMs can serve goals on different levels (several are often combined):
Patient level goals: screening for symptoms and problems, monitoring of
symptoms, aid decision making, facilitate communication with patients and
within the team
Service/setting level goals: evaluate and improve the quality of care
(e.g. services), demonstrate effect, promote good practice
Policy level goals: improving and monitoring palliative care practice on policy
level (e.g. recommended routine collection and minimum dataset)
POS measures
Palliative care Outcome Scale (POS) measures can serve all discussed goals
2 Select patients, setting, and timing of assessment Respondents: The ideal way to collect PROM data is patient report. In
palliative care, this can be difficult, in which case proxy rating is used
(family or professional). Measuring both patient and proxy ratings is ideal.
Family carers’ own needs should be measured
Setting: Measurement can be done both within/outside the clinical setting
and within/between visits
Timing: For screening PROMs are used once, for monitoring more often.
Measurement frequency and questionnaire length should be related. Some
argue that, ideally, no change in ‘window of measurement’ should be made.
However, flexibility might be needed, e.g. following a change in situation
or depending on patient preference
POS measures
POS measures have patient (all), family (POS), and staff (POS, IPOS) versions
Both screening and monitoring is possible
The measurement window of POS measures are either 3 ((APCA African)
POS, IPOS) or 7 days (POS-S, IPOS). In practice, POS measures can be
measured more flexibly, in response to clinical circumstances
3 Determine which questionnaire to use Take several factors into consideration in choosing outcome measure
e.g., aim of use, questionnaire available
Choose outcome measure based on evidence, with sound psychometric
properties and suited for the clinical task
Use multidimensional (specific or generic) measures which allow for
comparisons across settings and countries
POS measures:
POS (individual items and total score) has good psychometric properties.
POS-S/APCA African POS are validated, IPOS is being validated
POS measures are holistic, translated, can be used in various settings and
diseases and in clinical practice (e.g. to enhance patient management and
as a quality improvement tool)
4 Choose a mode for administering/scoring the questionnaire PROMS can be collected using self- and interview-administration,
while computer-completion is efficient
Explain to patients why PROMS are helpful
Pilot the measure with a few patients
POS measures
There are several ways to administer POS measures: i) leave the measure
with the patient (provide written or verbal information), ii) stay with the
patient (patient self-completes or practitioner helps), or iii) integrate
measurement into holistic assessment (staff version – for specialists only)
5 Design processes for reporting results PROM results should be shared with other health care practitioners
(who can provide assistance in how to respond to certain issues) and
the patient (it can integrate them as active member of the team)
Decide how to present results, e.g. numerical info (easy to generate) and/or
graphic representations (easy to interpret over time, but might be more
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patient-reported symptoms. We found it was necessary to
have both core recommendations, applicable for all symp-
tom levels, as well as responses that could be titrated up
with increasingly severe symptom scores. Accompanying
guidance on PROM implementation was also developed,
using an 8-step approach. By producing both types of evi-
dence, PROMs (and specifically POS, or similar tools) might
be more widely integrated in clinical care and their effects
on patients’ outcomes can be strengthened.
The potential of our guidance and CDST to improve pro-
vided care and patient outcomes is supported by accumulat-
ing evidence. The Australian Palliative Care Outcome
Collaboration showed that implementing PROMs nationally
in palliative care improved patients’ reported symptoms year
Table 1 Implementation guidance key recommendations (Continued)
difficult to integrate into standard workflow). Looking at scores over time
is also important
Deal with (and anticipate on) missing data, which might be more prominent
with long, paper/self-administrated PROMs and large sets. Avoiding missing
data is difficult in advanced disease, but can be anticipated upon by quality
control procedures (e.g. double checking). Recommendations have been
developed for handling missing data (see MORECare Statement [109])
Store data in accordance with legal requirements
POS measures
Scores related to individual items and summary score can be generated.
Summary scores highlight overall severity of needs, individual scores show
where specific problems lie
When analyzing, check your data and note missing values
6 Identify aids to facilitate score interpretation For measures responsive to change use (and determine) the minimum
clinically important difference (MCID – distinguishes between clinically
relevant and statistically significant changes
If available, published cut-off scores can help with interpreting scores
Guidelines or disease management pathways can be linked to PROM scores,
but clear guidance is unavailable for many symptoms/topics. They are simple
to understand, but do not provide information about clinical importance of
scores for an individual
POS measures
The interpretation of scores is guided by clinical expertise and patient’s condition.
The MCID for the POS is a one-point change
7 Develop strategies for responding to identified issues PROM scores should go into clinical notes, shared with clinicians/patients,
and used to improve care and influence decision-making; exploration with
patients can increase understanding but might be time-consuming
PROM scores might be integrated with other clinical data
Develop a routine for how PROM scores are used in ward rounds, team
meetings, other consultations
POS measures
A Clinical Decision Support Tool for POS items information needs, family
anxiety, depression, and breathlessness is developed
8 Evaluate the impact of measuring PROMs on practice Precondition for successful implementation: use change management
principles, facilitation, and communication to help embed PROM
measurement in clinical practice
Take into account described facilitators/barriers during preparing,
implementing, and evaluating PROM measurement in clinical care
Evaluate the impact of the PROM implementation, e.g. set up quality
improvement initiatives (audits/benchmarking), use different
(quasi/experimental) designs, evaluate implementation process,
relate to quality indicators
POS measures
Ensure that staff is positive and see the added value of using POS,
use a supportive training program to ensure routine uptake, and feed
results back to sustain staff commitment
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after year [89, 90]. Expert consensus underlines the import-
ance of coming to a routinely collected set of outcome mea-
sures, which can be used to make comparisons across
services and countries [21]. Our provided guidance might
assist in this development while overcoming some of the
perceived barriers of implementing PROMs, most notably a
lack of knowledge and education [6, 91].
The CDST can assist clinicians in responding to the psy-
chosocial aspects of clinical care which they may feel less
confident in delivering. Across the several symptoms in-
cluded in our Delphi, for higher scores, more intensive clin-
ical responses seem warranted. Ensuring the core
recommendations (good patient care; providing psychosocial
support and empathy; the use of open communication) are
in place remains vital in these situations. These core recom-
mendations reflect previous study findings, showing that pa-
tients expect their clinicians to show both technical
competence [92] as well as seeing them as an individual per-
son [93]. Empathy becomes increasingly important in pro-
gressing disease [94], while most medical complaints are
related to communication deficits [95, 96], adding not only
to patient but also caregiver distress [97]. Our CDST postu-
lates that proper assessment should be followed by non-
pharmacological interventions which can be progressed to
pharmacological interventions in the more medical oriented
symptoms of breathlessness and depression. However, also
in these domains, there seems a preference for psychosocial
interventions. Indeed, a recent RCT showed that a short-
term service provided by palliative care, respiratory,
physiotherapy, and occupational therapy improved breath-
less patients’ outcomes [98]. This service combined pharma-
cological review with a focus on non-pharmacological
interventions such as pacing and relaxation.
Although originally developed for the POS family of mea-
sures, the core recommendations point towards the potential
usefulness of our CDST for other PROMs covering similar
domains (e.g. the Edmonton Symptom Assessment System
[99], the McGill Quality of Life Questionnaire [100], or qual-
ity of life measures such as the EORTC-QLQC30 [101]). It
is a wider problem that in advanced illness patients’ and
caregivers’ psychosocial needs often remain unmet
[102, 103]. A recent systematic review, including but not
limited to POS, concluded that feeding back PROM data
in palliative care influenced patients’ psychosocial out-
comes the most [104]. Our CDST might strengthen this
finding by generalizing its applicability beyond POS.
Although the CDST proposals are based on scientific evi-
dence combined with expert opinion, this tool is not
intended to be prescriptive. Instead, it aims to help practi-
tioners think through the best decision towards difficult
and complex encountered problems. Being too prescrip-
tive can be counterproductive, especially because in ad-
vanced illness patients and families have complex and
often quite individual needs, circumstances, and
trajectories, which interact [1, 105]. Instead the CDST
should be used as the name implies, as a support, to aid a
wider range of aspects to be considered when making
treatment choices, alongside skilled individual clinical as-
sessment and knowledge, taking into account patients’
and families’ individual preferences, circumstances and
available resources. In areas of uncertainty or conflict, spe-
cialist support or a second opinion should be obtained.
The CDST should not be used as an endpoint (‘tick-box’
exercise) in itself but as a starting point to achieve high
quality person-centered care and good clinical practice.
As the implementation guide makes clear, training and
ongoing support will be an essential component.
This study has limitations. Our sample size was relatively
small, although it should be noted that the responses rates
in the online Delphi (66 % vs 62 %) are in line with a previ-
ous similar study in this field [106]. Next, we asked partici-
pants in the Delphi study to review a wide area of topics,
which might have been challenging, especially surrounding
the specific topic of breathlessness. However, as palliative
care focuses on physical, psychological, emotional, and spir-
itual issues, we anticipated most participants to have (some)
knowledge in all domains and added a ‘do not know’ op-
tion in the Delphi. The quality rating should also be inter-
preted with caution as we used an adapted GRADE
approach. Many sources used different rating systems and
we followed sources’ own evidence-levels if already pro-
vided. No strength of recommendation (representing
whether desirable effects of recommendations clearly
outweigh (or not) undesirable effects [44]) was provided
due to the heterogeneity of used quality ratings and the
envisaged applicability of our recommendations in dif-
ferent settings and countries. Lower ratings do not ne-
cessarily imply that these recommendations are not
important, as they were among the highest rated rec-
ommendations by our expert panel (e.g. the provision
of emotional support and respect for cultural/religious
traditions when handling family anxiety). These ratings
also highlight the pressing need for more high-quality
research studies to build the evidence-base of these and
other key components of palliative care. For example,
the use of a fan was labelled as ‘no evidence’ based on
a Cochrane review [59]. However, this is still in the
early stages of evaluation, with recent studies showing
conflicting effects (e.g. [107, 108]). As fans are inexpen-
sive, unlike to cause any harm and have low side ef-
fects, they can be worth trying. Another limitation
entailed that we only included sources that focused on
palliative care in general and not on specific diseases as
we sought recommendations that were applicable
across diseases. For some diseases, the evidence might
propose alternative strategies; however, we would ex-
pect experts in those fields to be aware of this evidence
to take it into consideration. Although we used a broad
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search strategy, relevant sources might have been
missed. Furthermore, we refer in footnotes to the Ci-
cely Saunders Institute’s Breathlessness Intervention
Service and the Vitaltalk organization for more re-
sources on breathlessness and information needs. These
were not found via our search strategies (as they are
very recent), but we believed them to be of importance
to clinical care. Finally, due to time and resource con-
straints, only one author identified resources and ex-
tracted data of included sources. That being said, a
major strength of this work includes the involvement of
patients and families in the development of the CDST
and the combination of evidence-based recommenda-
tions with clinician expertise. Future studies can use
this study as a starting point in developing evidence-
based CDST for advanced disease, and should now re-
fine our proposed CDST, test its effect on patient and
family outcomes, and develop CDST for other POS
items.
Conclusions
Our findings underline the importance of providing good
patient care, psychosocial support and empathy, and com-
munication in advanced disease for all patients and
families, irrespective of POS scores, in the domains
of information needs, family anxiety, depression, and
breathlessness. For increasing scores, patients’ symptoms
should be assessed and responded to with non-
pharmacological interventions, followed by pharmaco-
logical interventions (for breathlessness and depression).
We were able to develop these recommendations into a
CDST. Our novel evidenced-based approach to develop a
CDST offers a replicable method for other areas. By using
the presented recommendations alongside skilled clinical
knowledge and patient preferences and ongoing training,
it aims to help support clinicians provide the best pos-
sible patient-centered care and patients and their families
achieve the best possible outcomes in highly threatening
times. Systematically following the 8-step framework can
support successful implementation of PROMS, and POS,
in advanced disease.
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